| Mobile Web

All articles List

Industry

Moderna, Merck personalised mRNA cancer vaccine cuts melanoma recurrence or death risk by 42%

A personalised mRNA cancer vaccine being co-developed by Moderna and Merck reduced the risk of recurrence or death in melanoma patients by 42%, the report said. In a phase 3 trial involving 1,137 patients who had tumours removed by surgery, those receiving the vaccine intismeran with Merck's Keytruda outperformed a Keytruda-plus-placebo group. The companies are discussing approval procedures with regulators, with detailed results due at a European oncology meeting in Madrid.

AI & Enterprise

Anthropic core team says Claude now writes almost all code

Code-writing work in Anthropic's core platform engineering organisation has effectively shifted to Claude, Business Insider reported. Caitlin Lese (케이틀린 레세), who leads the platform engineering group, said all team code is written by Claude as the company builds and maintains internal systems. Employees still handle system design and verification. Anthropic is also considering letting agents autonomously change real codebases as model performance improves.

Crypto

Whale buys $7.22 million worth of nine small-cap altcoins in downturn

A whale wallet has bought $7.22 million worth of mid- to small-cap altcoins over the past 24 hours, spreading funds across nine assets that were mainly tied to DeFi and real-world asset projects. The biggest purchase was LIT, followed by ENA and ONDO. Short-term price moves diverged among the main tokens. The buying has been linked to bargain hunting and theme-based positioning, though a single wallet’s activity does not guarantee a rebound.